Summary. Consider a meta-analysis of studies with varying proportions of patient-level missing data, and assume that each primary study has made certain missing data adjustments so that the reported estimates of treatment effect size and variance are valid. These estimates of treatment effects can be combined across studies by standard meta-analytic methods, employing a random-effects model to account for heterogeneity across studies. However, we note that a meta-analysis based on the standard random-effects model will lead to biased estimates when the attrition rates of primary studies depend on the size of the underlying study-level treatment effect. Perhaps ignorable within each study, these types of missing data are in fact not ignorabl...
Phase I trials aim to establish appropriate clinical and statistical parameters to guide future clin...
Classical meta-analysis requires the same data from each clinical trial, thus data-reporting must be...
Missing outcome data of trial participants is a frequent phenomenon in RCTs and may represent a seri...
Consider a meta-analysis of studies with varying proportions of patient-level missing data, and assu...
Objective Missing outcome data are a common problem in clinical trials and systematic reviews, as it...
Missing outcome data are commonly encountered in randomized controlled trials and hence may need to ...
Abstract Background When potentially associated with ...
Missing participant outcome data (MOD) are ubiquitous in clinical trials and may threaten the validi...
The use of the last observation carried forward (LOCF) method for imputing missing outcome data in r...
Meta-analysis collects and synthesizes results from individual studies to estimate an overall effect...
Missing data occur frequently in meta-analy-sis. Reviewers inevitably face decisions about how to ha...
Thesis (Ph.D.)--University of Rochester. School of Medicine & Dentistry. Dept. of Biostatistics and ...
The use of the last observation carried forward (LOCF) method for imputing missing outcome data in r...
OBJECTIVE: To examine whether the association of inadequate or unclear allocation concealment and la...
When study variances are not reported or ‘missing”, it is common practice in meta analysis to assume...
Phase I trials aim to establish appropriate clinical and statistical parameters to guide future clin...
Classical meta-analysis requires the same data from each clinical trial, thus data-reporting must be...
Missing outcome data of trial participants is a frequent phenomenon in RCTs and may represent a seri...
Consider a meta-analysis of studies with varying proportions of patient-level missing data, and assu...
Objective Missing outcome data are a common problem in clinical trials and systematic reviews, as it...
Missing outcome data are commonly encountered in randomized controlled trials and hence may need to ...
Abstract Background When potentially associated with ...
Missing participant outcome data (MOD) are ubiquitous in clinical trials and may threaten the validi...
The use of the last observation carried forward (LOCF) method for imputing missing outcome data in r...
Meta-analysis collects and synthesizes results from individual studies to estimate an overall effect...
Missing data occur frequently in meta-analy-sis. Reviewers inevitably face decisions about how to ha...
Thesis (Ph.D.)--University of Rochester. School of Medicine & Dentistry. Dept. of Biostatistics and ...
The use of the last observation carried forward (LOCF) method for imputing missing outcome data in r...
OBJECTIVE: To examine whether the association of inadequate or unclear allocation concealment and la...
When study variances are not reported or ‘missing”, it is common practice in meta analysis to assume...
Phase I trials aim to establish appropriate clinical and statistical parameters to guide future clin...
Classical meta-analysis requires the same data from each clinical trial, thus data-reporting must be...
Missing outcome data of trial participants is a frequent phenomenon in RCTs and may represent a seri...